1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Bangladesh Pharmaceuticals and Healthcare Report Q3 2016

Bangladesh Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 90 pages

Includes 3 FREE quarterly updates

BMI View: Replicating India's success in the generic drugs sector will remain a challenge for Bangladesh.The country's strategy of leveraging upon an extension of the patent waiver for least developed countriespresents limited opportunities, as many of these markets have low levels of healthcare access and per capitapharmaceutical spending. Moreover, the key growth opportunities for generics medicines lie in theemerging countries and selected developed markets where Bangladesh firms will have to work within theintellectual property framework.

Headline Expenditure Projections

- Pharmaceuticals: BDT171.6bn (USD2.2bn) in 2015 to BDT190.8bn (USD2.4bn) in 2016; +11.2% inlocal currency terms and +9.1% in US dollar terms.

- Healthcare: BDT419bnbn (USD5.3bn) in 2015 to BDT460bnbn (USD5.7bn) in 2016; +9.9% in localcurrency terms and +7.6% in US dollar terms.

Table Of Contents

Bangladesh Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Bangladesh 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bangladesh 2012-2020) 12
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bangladesh 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Bangladesh 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Bangladesh 2014-2020) 28
Pharmaceuticals and Healthcare Risk/Reward Index 29
Asia Pacific Risk/Reward Index - Q3 2016 29
Bangladesh Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Table: Steps To Establish A Pharmaceutical Manufacturing Unit And Obtain A Drug Manufacturing Licence 39
Intellectual Property Issues 39
Pricing and Reimbursement Regime 41
Market Overview 44
Healthcare Sector 44
Table: Healthcare Resources (Bangladesh 2010-2015) 51
Table: Healthcare Personnel (Bangladesh 2010-2015) 51
Table: Healthcare Activity (Bangladesh 2010-2015) 52
Research and Development 53
Table: Suggestions Made By University Of Dhaka's Faculty Of Pharmacy To Improve Pharmaceutical Research 54
Clinical Trials 55
Epidemiology 56
Competitive Landscape 59
Research-Based Industry 59
Table: Table: Multinational Market Activity 62
Pharmaceutical Distribution 63
Company Profile 64
Beximco Pharmaceuticals 64
Eskayef 67
Renata 70
Sanofi 73
Square Pharmaceuticals 76
Demographic Forecast 79
Table: Population Headline Indicators (Bangladesh 1990-2025) 80
Table: Key Population Ratios (Bangladesh 1990-2025) 80
Table: Urban/Rural Population and Life Expectancy (Bangladesh 1990-2025) 81
Table: Population By Age Group (Bangladesh 1990-2025) 81
Table: Population By Age Group % (Bangladesh 1990-2025) 82
Glossary 84
Methodology 86
Pharmaceutical Expenditure Forecast Model 86
Healthcare Expenditure Forecast Model 86
Notes On Methodology 87
Risk/Reward Index Methodology 88
Index Overview 89
Table: Pharmaceutical Risk/Reward Index Indicators 89
Indicator Weightings 90

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.